Executive Summary of the Vulvodynia Therapeutic Research Summit.
Obstetrics and gynecology. 2026 Feb; 147(Feb):266-276. doi: 10.1097/AOG.0000000000006118. pii: .
Base: PUBMEDEndometrial cancer therapy in 2026.
Current opinion in obstetrics & gynecology. 2026 Feb; 38(Feb):22-33. doi: 10.1097/GCO.0000000000001078. pii: .
Base: PUBMEDSelf-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline.
CA: a cancer journal for clinicians. 2026 ; 76():e70041. doi: 10.3322/caac.70041. pii: e70041.
Base: PUBMEDQuadrivalent Human Papillomavirus Vaccine and High-Grade Vulvovaginal Lesions.
JAMA oncology. 2026 Feb; 12(Feb):177-184. doi: 10.1001/jamaoncol.2025.5511. pii: .
Base: PUBMEDResource-Based Good Clinical Practice Recommendations for Colposcopy Standards and Quality Assurance in Colposcopy Practice.
Journal of lower genital tract disease. 2026 Jan; 30(Jan):88-96. doi: 10.1097/LGT.0000000000000921. pii: .
Base: PUBMEDNoninferiority of One HPV Vaccine Dose to Two Doses.
The New England journal of medicine. 2025 Dec; 393(Dec):2421-2433. doi: 10.1056/NEJMoa2506765. pii: .
Base: PUBMEDNew developments in the treatment of cervical cancer in 2026.
Current opinion in obstetrics & gynecology. 2026 Feb; 38(Feb):14-21. doi: 10.1097/GCO.0000000000001079. pii: .
Base: PUBMEDUpdates in palliative care of patients with gynecologic malignancies in 2026: early integration, resource models, and emerging therapies.
Current opinion in obstetrics & gynecology. 2026 Feb; 38(Feb):1-5. doi: 10.1097/GCO.0000000000001077. pii: .
Base: PUBMEDZoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial.
Lancet (London, England). 2026 Jan; 407(Jan):147-160. doi: 10.1016/S0140-6736(25)01953-1. pii: S0140-6736(25)01953-1.
Base: PUBMEDTowards shorter therapy for candidaemia: defining uncomplicated candidaemia in adults.
The Lancet. Infectious diseases. 2026 Feb; 26(Feb):e112-e123. doi: 10.1016/S1473-3099(25)00409-8. pii: S1473-3099(25)00409-8.
Base: PUBMEDBeyond minimum inhibitory concentrations: Integrating molecular resistance testing for equitable management of vaginal candidiasis.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2026 Jan; 162(Jan):108201. doi: 10.1016/j.ijid.2025.108201. pii: S1201-9712(25)00423-0.
Base: PUBMEDAdvances in treating bacterial vaginosis: recognizing sexual transmission and pipeline of therapies.
Current opinion in infectious diseases. 2026 Feb; 39(Feb):67-74. doi: 10.1097/QCO.0000000000001172. pii: .
Base: PUBMEDDevelopments in genital herpes: progress in prevention and treatment.
Current opinion in infectious diseases. 2026 Feb; 39(Feb):61-66. doi: 10.1097/QCO.0000000000001177. pii: .
Base: PUBMEDCandidiasis: a novel molecular differential diagnosis through real-time PCR followed by high-resolution thermal denaturation.
Diagnostic microbiology and infectious disease. 2025 Aug; 114(Aug):117058. doi: 10.1016/j.diagmicrobio.2025.117058. pii: S0732-8893(25)00381-5.
Base: PUBMEDState of the Art for Regenerative Management of Vulvar Lichen Sclerosus.
Aesthetic plastic surgery. 2025 Dec; 49(Dec):6838-6842. doi: 10.1007/s00266-025-05459-7. pii: .
Base: PUBMEDHuman papillomavirus self-collection: The long road from scientific evaluation to implementation in screening programs.
CA: a cancer journal for clinicians. 2026 ; 76():e70047. doi: 10.3322/caac.70047. pii: e70047.
Base: PUBMEDLongitudinal Testing of Anal Cytology and Human Papillomavirus in Females With Lower Genital Tract Dysplasia or Cancer.
Journal of lower genital tract disease. 2026 Jan; 30(Jan):76-82. doi: 10.1097/LGT.0000000000000917. pii: .
Base: PUBMEDEffect of Prior 9-Valent Human Papillomavirus Vaccination on Subsequent Lower Genital Tract Dysplasia After Cervical Excisional Surgery.
Obstetrics and gynecology. 2026 Jan; 147(Jan):73-82. doi: 10.1097/AOG.0000000000006113. pii: .
Base: PUBMEDClinical Performance of HPV DNA and HPV RNA Assays for the Detection of High-Grade Cervical Lesions.
Journal of lower genital tract disease. 2026 Jan; 30(Jan):25-30. doi: 10.1097/LGT.0000000000000925. pii: .
Base: PUBMEDMIRaGE (Minimally Invasive suRGery in recurrent Endometrial cancer).
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2025 Dec; 35(Dec):102726. doi: 10.1016/j.ijgc.2025.102726. pii: S1048-891X(25)01846-8.
Base: PUBMEDEvaluation of toxicity after radical hysterectomy or trachelectomy and post-operative pelvic intensity-modulated radiation therapy with concurrent chemotherapy for cervical cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2025 Dec; 35(Dec):102712. doi: 10.1016/j.ijgc.2025.102712. pii: S1048-891X(25)01832-8.
Base: PUBMEDPrognostic and therapeutic implications of clinical-radiologic discrepancy in parametrial invasion prior to primary radical hysterectomy in cervical cancer.
Gynecologic oncology reports. 2026 Feb; 63(Feb):102002. doi: 10.1016/j.gore.2025.102002. pii: 102002.
Base: PUBMEDImage-guided surgical navigation for inguinal sentinel lymph node procedures in vulvar cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2025 Dec; 35(Dec):102714. doi: 10.1016/j.ijgc.2025.102714. pii: S1048-891X(25)01834-1.
Base: PUBMEDEffects of Adherence to Colposcopy Guidelines on the Detection of Cervical Intraepithelial Neoplasia.
Journal of lower genital tract disease. 2026 Jan; 30(Jan):17-21. doi: 10.1097/LGT.0000000000000918. pii: .
Base: PUBMEDThe Role of Cervical or Vaginal HPV Testing in Surveillance of Vulvar, Vaginal, and Anal HPV-Associated Neoplasia.
Journal of lower genital tract disease. 2026 Jan; 30(Jan):1-9. doi: 10.1097/LGT.0000000000000920. pii: .
Base: PUBMEDInterobserver Variation in Vulvar Squamous Cell Cancer Depth of Invasion Using Two Measurement Methods.
Journal of lower genital tract disease. 2025 Oct; 29(Oct):304-309. doi: 10.1097/LGT.0000000000000909. pii: .
Base: PUBMEDDynamic Spectral Imaging and Regular Colposcopy in CIN2+ Detection for HPV-Positive and/or Low-Grade Cytology Referrals.
Journal of lower genital tract disease. 2025 Oct; 29(Oct):335-341. doi: 10.1097/LGT.0000000000000910. pii: .
Base: PUBMEDFrom inflammation to invasion: neutrophils in cervical cancer pathogenesis.
Annals of medicine and surgery (2012). 2025 Nov; 87(Nov):7112-7127. doi: 10.1097/MS9.0000000000002679. pii: .
Base: PUBMEDDiagnostic Performance of the PrevoCheck for the Detection of Human Papillomavirus 16-Driven Head and Neck Squamous Cell Carcinoma.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 2025 Nov; doi: 10.1111/jop.70075. pii: .
Base: PUBMEDEffects of human papillomavirus (HPV) vaccination programmes on community rates of HPV-related disease and harms from vaccination.
The Cochrane database of systematic reviews. 2025 Nov; 11(Nov):CD015363. doi: 10.1002/14651858.CD015363.pub2. pii: CD015363.
Base: PUBMEDComparative Efficacy of Photodynamic Therapy and Cold Knife Conization for Cervical High-Grade Squamous Intraepithelial Lesions.
Current oncology (Toronto, Ont.). 2025 Oct; 32(Oct):doi: 10.3390/curroncol32110590. pii: 590.
Base: PUBMEDHPV Testing, Self-Collection, and Vaccination: A Comprehensive Approach to Cervical Cancer Prevention.
Current oncology (Toronto, Ont.). 2025 Oct; 32(Oct):doi: 10.3390/curroncol32110594. pii: 594.
Base: PUBMEDFIGO position statement on the effectiveness and safety of the HPV vaccine.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2025 Nov; 171(Nov):545-549. doi: 10.1002/ijgo.70506. pii: .
Base: PUBMEDConsensus on Quality Standards for Colposcopy and Colposcopy Training From the Latin-American Federation of Lower Genital Tract Pathology and Colposcopy.
Journal of lower genital tract disease. 2025 Oct; 29(Oct):329-334. doi: 10.1097/LGT.0000000000000908. pii: .
Base: PUBMEDHigh-Risk HPV Testing in Head and Neck Carcinoma: Key Updates from the 2025 College of American Pathologists Guideline.
Head and neck pathology. 2025 Sep; 19(Sep):115. doi: 10.1007/s12105-025-01847-2. pii: .
Base: PUBMEDUpdated ESUR Guidelines for Endometrial Cancer: integrating MRI with the 2023 FIGO Staging Revolution.
European radiology. 2025 Jun; doi: 10.1007/s00330-025-11700-3. pii: .
Base: PUBMEDActive surveillance of cervical intraepithelial neoplasia grade 2: 2025 British Society of Colposcopy and Cervical Pathology and European Society of Gynaecologic Oncology consensus statement.
The Lancet. Oncology. 2025 Mar; 26(Mar):e140-e151. doi: 10.1016/S1470-2045(24)00524-2. pii: S1470-2045(24)00524-2.
Base: PUBMEDSelf-Collected Vaginal Specimens for HPV Testing: Recommendations From the Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee.
Journal of lower genital tract disease. 2025 Apr; 29(Apr):144-152. doi: 10.1097/LGT.0000000000000885. pii: .
Base: PUBMEDEuroGuiderm guideline on lichen sclerosus-Treatment of lichen sclerosus.
Journal of the European Academy of Dermatology and Venereology : JEADV. 2024 Oct; 38(Oct):1874-1909. doi: 10.1111/jdv.20083. pii: .
Base: PUBMEDVulvar inspection at the time of cervical cancer screening: European Society of Gynaecological Oncology (ESGO), International Society for the Study of Vulvovaginal Disease (ISSVD), European College for the Study of Vulval Disease (ECSVD), and European Federation for Colposcopy (EFC) consensus statements.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2025 Jan; 35(Jan):100007. doi: 10.1016/j.ijgc.2024.100007. pii: S1048-891X(24)00033-1.
Base: PUBMEDApplying Results of Extended Genotyping to Management of Positive Cervicovaginal Human Papillomavirus Test Results: Enduring Guidelines.
Journal of lower genital tract disease. 2025 Apr; 29(Apr):134-143. doi: 10.1097/LGT.0000000000000865. pii: .
Base: PUBMEDNeoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2025 Mar; 43(Mar):868-891. doi: 10.1200/JCO-24-02589. pii: .
Base: PUBMED2024 European guidelines for the management of genital herpes.
Journal of the European Academy of Dermatology and Venereology : JEADV. 2025 Apr; 39(Apr):742-758. doi: 10.1111/jdv.20450. pii: .
Base: PUBMEDSEOM-GEICO Clinical Guidelines on cervical cancer (2023).
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2024 Nov; 26(Nov):2771-2782. doi: 10.1007/s12094-024-03604-3. pii: .
Base: PUBMEDEuropean Board and College of Obstetrics and Gynaecology (EBCOG) position statement on the use of laser vaginal devices for treatment of genitourinary syndrome of menopause, vaginal laxity, pelvic organ prolapse and stress urinary incontinence.
European journal of obstetrics, gynecology, and reproductive biology. 2024 Aug; 299(Aug):342-344. doi: 10.1016/j.ejogrb.2024.05.021. pii: S0301-2115(24)00251-3.
Base: PUBMEDFIGO-GCH joint consensus statement on the current status and recommendations for the use of blind intrauterine procedures in the evaluation and management of women with suspected intrauterine pathologies.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2025 Feb; 168(Feb):493-496. doi: 10.1002/ijgo.16078. pii: .
Base: PUBMEDConsensus on drivers of maintenance treatment choice and patterns of care in advanced ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2024 Oct; doi: 10.1136/ijgc-2024-005497. pii: ijgc-2024-005497.
Base: PUBMEDThe European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus statement on the management of vaginal intraepithelial neoplasia.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2023 Apr; 33(Apr):446-461. doi: 10.1136/ijgc-2022-004213. pii: .
Base: PUBMEDDiagnosis and Management of Vulvar Skin Disorders: ACOG Practice Bulletin, Number 224.
Obstetrics and gynecology. 2020 07; 136(07):e1-e14. doi: 10.1097/AOG.0000000000003944. pii: .
Base: PUBMEDCervical cancer screening in high-risk patients: Clinical challenges in primary care.
Cleveland Clinic journal of medicine. 2024 Nov; 91(Nov):693-703. doi: 10.3949/ccjm.91a.24023. pii: .
Base: PUBMEDScreening of Anal HPV Precancerous Lesions: A Review after Last Recommendations.
Journal of clinical medicine. 2024 Sep; 13(Sep):doi: 10.3390/jcm13175246. pii: 5246.
Base: PUBMEDESGO/EURACAN/GCIG guidelines for the management of patients with uterine sarcomas.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2024 Oct; 34(Oct):1499-1521. doi: 10.1136/ijgc-2024-005823. pii: .
Base: PUBMEDWHO International Standards for antibodies to HPV6 HPV11 HPV31 HPV33 HPV45 HPV52 and HPV58.
NPJ vaccines. 2024 Sep; 9(Sep):165. doi: 10.1038/s41541-024-00949-2. pii: 165.
Base: PUBMEDEuroGuiderm guideline on lichen sclerosus-introduction into lichen sclerosus.
Journal of the European Academy of Dermatology and Venereology : JEADV. 2024 Oct; 38(Oct):1850-1873. doi: 10.1111/jdv.20082. pii: .
Base: PUBMEDNCCN Guidelines® Insights: Cervical Cancer, Version 1.2024.
Journal of the National Comprehensive Cancer Network : JNCCN. 2023 Dec; 21(Dec):1224-1233. doi: 10.6004/jnccn.2023.0062. pii: .
Base: PUBMEDBritish association for sexual health and HIV national guideline for the management of anogenital warts in adults (2024).
International journal of STD & AIDS. 2024 Jun; 35(Jun):498-509. doi: 10.1177/09564624241233338. pii: .
Base: PUBMEDDiagnosis and Management of Vulvar Skin Disorders: ACOG Practice Bulletin Summary, Number 224.
Obstetrics and gynecology. 2020 Jul; 136(Jul):222-225. doi: 10.1097/AOG.0000000000003945. pii: .
Base: PUBMEDQuadrivalent Human Papillomavirus Vaccine and High-Grade Vulvovaginal Lesions.
JAMA oncology. 2026 Feb; 12(Feb):177-184. doi: 10.1001/jamaoncol.2025.5511. pii: .
Base: PUBMEDNew developments in the treatment of cervical cancer in 2026.
Current opinion in obstetrics & gynecology. 2026 Feb; 38(Feb):14-21. doi: 10.1097/GCO.0000000000001079. pii: .
Base: PUBMEDEndometrial cancer therapy in 2026.
Current opinion in obstetrics & gynecology. 2026 Feb; 38(Feb):22-33. doi: 10.1097/GCO.0000000000001078. pii: .
Base: PUBMEDUpdates in palliative care of patients with gynecologic malignancies in 2026: early integration, resource models, and emerging therapies.
Current opinion in obstetrics & gynecology. 2026 Feb; 38(Feb):1-5. doi: 10.1097/GCO.0000000000001077. pii: .
Base: PUBMEDPrognostic and therapeutic implications of clinical-radiologic discrepancy in parametrial invasion prior to primary radical hysterectomy in cervical cancer.
Gynecologic oncology reports. 2026 Feb; 63(Feb):102002. doi: 10.1016/j.gore.2025.102002. pii: 102002.
Base: PUBMEDExecutive Summary of the Vulvodynia Therapeutic Research Summit.
Obstetrics and gynecology. 2026 Feb; 147(Feb):266-276. doi: 10.1097/AOG.0000000000006118. pii: .
Base: PUBMEDDevelopments in genital herpes: progress in prevention and treatment.
Current opinion in infectious diseases. 2026 Feb; 39(Feb):61-66. doi: 10.1097/QCO.0000000000001177. pii: .
Base: PUBMEDAdvances in treating bacterial vaginosis: recognizing sexual transmission and pipeline of therapies.
Current opinion in infectious diseases. 2026 Feb; 39(Feb):67-74. doi: 10.1097/QCO.0000000000001172. pii: .
Base: PUBMEDTowards shorter therapy for candidaemia: defining uncomplicated candidaemia in adults.
The Lancet. Infectious diseases. 2026 Feb; 26(Feb):e112-e123. doi: 10.1016/S1473-3099(25)00409-8. pii: S1473-3099(25)00409-8.
Base: PUBMEDZoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial.
Lancet (London, England). 2026 Jan; 407(Jan):147-160. doi: 10.1016/S0140-6736(25)01953-1. pii: S0140-6736(25)01953-1.
Base: PUBMED